Discovering a new role for a breast cancer gene

January 18, 2013

(Medical Xpress)—Researchers at the School of Biosciences have identified an unexpected role for a tumour-associated gene in breast cancer.

Previous studies using tumour cells grown in the laboratory had suggested that the gene, Bcl3, regulated tumour growth.  However when the research team, led by Dr Richard Clarkson, looked at the effect of suppressing this gene in mammary tumours inside the body, they found that this had no effect on tumour growth, but instead prevented the tumours from spreading to other organs.  This is significant because tumour spread (metastasis) is the major cause of death in .

"We have identified an unexpected role for this gene in living tissues, which we would not have predicted from studies of grown outside of the body." Dr Clarkson explained.  "This approach has also revealed that suppressing this gene is not harmful to normal tissues, which makes Bcl3 a promising for breast cancer".  

The results of this study, which have been reported in the leading cancer journal Cancer Research, has led the research team to develop novel pharmacological inhibitors of Bcl3.  These inhibitors are currently undergoing pre-clinical tests to evaluate their potential as anti- that could prevent the spread of cancer, in patients with aggressive forms of breast disease.

Explore further: Scientists find gene that inhibits pancreas cancer spread

More information: www.ncbi.nlm.nih.gov/pubmed?te … Clarkson%20wakefield

Related Stories

Scientists find gene that inhibits pancreas cancer spread

April 29, 2012
Scientists have identified a gene that slows the spread of pancreatic cancer tumours, paving the way for targeted treatment of one of the deadliest forms of the disease, said a paper published Sunday.

Treatment of common virus can reduce tumour growth

September 27, 2011
Researchers at Karolinska Institutet in Sweden have demonstrated for the first time that it is possible to inhibit the growth of brain tumours by treating the common Cytomegalovirus (CMV). The virus, which is found in a wide ...

A new indicator for breast cancer relapse identified

June 19, 2012
Researchers at the IMIM (Institut de Recerca Hospital del Mar) have proven that the absence of the 14-3-3 protein sigma in breast cancer cells is directly associated with these cells' capacity to activate the signalling of ...

Silencing a deadly conversation in breast cancer

June 2, 2011
While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning ...

RANK protein promotes the initiation, progression and metastasis of human breast cancer

April 24, 2012
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.